This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsAbbreviations
- Ag:
-
Antigen
- DC:
-
Dendritic cells
- GM-CSF:
-
Granulocyte macrophage-colony stimulating factor
- GvHD:
-
Graft-versus-Host Disease
- HGF:
-
Hepatocyte growth factor
- HO-1:
-
Haemoxygenase-1
- HSCT:
-
Hematopoietic stem cell transplantation
- IDO:
-
Indoleamine 2,3-dioxygenase
- IFN-γ :
-
Interferon-γ
- IL:
-
Interleukin
- LPS:
-
Lipopolysaccharide
- MHC:
-
Major histocompatibility complex
- MLR:
-
Mixed lymphocyte reactions
- MSC:
-
Mesenchymal stem cells
- NK cells:
-
Natural killer cells
- NO:
-
Nitric oxide
- PGE2:
-
Prostaglandin E2
- TGF-β :
-
Transforming growth factor-β
- TNF-α :
-
Tumor necrosis factor-α
References
Aggarwal S, Pittenger MF (2005) Human mesenchymal stem cells modulate allogeneic immune responses. Blood 105:1815–1822
Aldinucci A, Rizzetto L, Pieri L et al (2010) Inhibition of immune synapse by altered dendritic cell actin distribution: a new pathway of mesenchymal stem cell immune regulation. J Immunol 185:5102–5110
Ball LM, Bernardo ME, Roelofs H et al (2007) Cotransplantation of ex vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation. Blood 110:2764–2767
Banchereau J, Steinman RM (1998) Dendritic cells and the control of immunity. Nature 392:245–252
Banchereau J, Briere F, Caux F et al (2000) Immunobiology of dendritic cells. Annu Rev Immunol 18:767–811
Bassi EJ, de Almeida DC, Moraes-Vieira PM et al (2012) Exploring the role of soluble factors associated with immune regulatory properties of mesenchymal stem cells. Stem Cell Rev Rep 8:329–342
Battiwalla M, Hematti P (2009) Mesenchymal stem cells in hematopoietic stem cell transplantation. Cytotherapy 11:503–515
Beyth S, Borovsky Z, Mevorach D et al (2005) Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood 105:2214–2219
Cooper MA, Fehniger TA, Fuchs A et al (2004) NK cell and DC interactions. Trends Immunol 25:47–52
Jiang X-X, Zhang Y, Liu B et al (2005) Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. Blood 105:4120–4126
Krampera M (2011) Mesenchymal stromal cell “licensing”: a multistep process. Leukemia 25:1408–1414
Krampera M, Cosmi L, Angeli R et al (2006) Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells. Stem Cells 24:386–398
Le Blanc K, Frassoni F, Ball LM et al (2008) Mesenchymal stem cells for treatment of steroid-resistant severe, acute graft-versus-host disease: a phase II study. Lancet 371:1579–1586
Li Y-P, Paczesny S, Lauret E et al (2008) Human mesenchymal stem cells license adult CD34+ hemopoietic progenitor cells to differentiate into regulatory dendritic cells through activation of the Notch pathway. J Immunol 180:1598–1608
Méndez-Ferrer S, Michurina TV, Ferraro F et al (2010) Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 466:829–834
Moretta A (2002) Natural killer cells and dendritic cells: rendezvous in abused tissues. Nat Rev Immunol 2:957–965
Moretta L, Ferlazzo G, Bottino C et al (2006) Effector and regulatory events during natural killer-dendritic cell interactions. Immunol Rev 214:219–228
Nauta AJ, Fibbe WE (2007) Immunomodulatory properties of mesenchymal stromal cells. Blood 110:3499–3506
Nauta AJ, Kruisselbrink AB, Lurvink E et al (2006) Mesenchymal stem cells inhibit generation and function of both CD34+-derived and monocyte-derived dendritic cells. J Immunol 177:2080–2087
Pittenger MF, Mackay AM, Beck SC et al (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284:143–147
Ramasamy R, Fazekasova H, Lam EW et al (2007) Mesenchymal stem cells inhibit dendritic cell differentiation and function by preventing entry into the cell cycle. Transplantation 83:71–76
Spaggiari GM, Abdelrazik H, Becchetti F et al (2009) Mesenchymal stem cells inhibit dendritic cell maturation and function by selectively interfering with the generation of immature DCs: central role of MSC-derived prostaglandin E2. Blood 113:6576–6583
Tolar J, Le Blanc K, Keating A et al (2010) Concise review: hitting the right spot with mesenchymal stromal cells. Stem Cells 28:1446–1455
Uccelli A, Moretta L, Pistoia V (2008) Mesenchymal stem cells in health and disease. Nat Rev Immunol 8:726–736
van den Berk LC, Roelofs H, Huijs T et al (2009) Cord blood mesenchymal stem cells propel human dendritic cells to an intermediate maturation state and boost interleukin-12 production by mature dendritic cells. Immunology 128:564–572
Zhao Z-G, Xu W, Sun L et al (2012) Immunomodulatory function of regulatory dendritic cells induced by mesenchymal stem cells. Immunol Invest 41:183–198
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 2013
About this chapter
Cite this chapter
Spaggiari, G.M., Moretta, L. (2012). Interactions Between Mesenchymal Stem Cells and Dendritic Cells. In: Weyand, B., Dominici, M., Hass, R., Jacobs, R., Kasper, C. (eds) Mesenchymal Stem Cells - Basics and Clinical Application II. Advances in Biochemical Engineering/Biotechnology, vol 130. Springer, Berlin, Heidelberg. https://doi.org/10.1007/10_2012_154
Download citation
DOI: https://doi.org/10.1007/10_2012_154
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-37943-7
Online ISBN: 978-3-642-37944-4
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)